Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Dermatology|March 15, 2006
Development and evaluation of sesamol as an antiaging agentShringi Sharma, Indu Pal Kaur
Drug Discovery Today|January 28, 2003
Permeability issues in nasal drug deliveryPriyanka Arora, Shringi Sharma, Sanjay Garg
Clinical Pharmacokinetics|August 6, 2015
Clinical Pharmacokinetic and Pharmacodynamic Profile of IdelalisibSrinivasan Ramanathan, Feng Jin, Shringi Sharma, et al.
Clinical Pharmacokinetics|March 13, 2015
Population Pharmacokinetics of ABT-806, an Investigational Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody, in Advanced Solid Tumor Types Likely to Either Over-Express Wild-Type EGFR or Express Variant III Mutant EGFRShringi Sharma, Rajendar K Mittapalli, Kyle D Holen, et al.
Journal of Clinical Pharmacology|March 30, 2026
Learnings from Approved Antibody-Drug Conjugates: Clinical Pharmacology PerspectivesBhargavi Thalluri, Aarti Sawant, Pavan Vajjah, et al.
Pharmaceutical Research|April 28, 2022
Physiologically Based Absorption Modelling to Explore the Formulation and Gastric pH Changes on the Pharmacokinetics of AcalabrutinibDiansong Zhou, Buyun Chen, Shringi Sharma, et al.
Clinical and Translational Science|August 21, 2024
Predicting progression-free survival from measurable residual disease in chronic lymphocytic leukemiaFlorencia A Tettamanti, Holly Kimko, Shringi Sharma, et al.
American Journal of Obstetrics and Gynecology|April 26, 2024
The dosing regimen for 17-hydroxyprogesterone caproate was suboptimal: lessons for future pharmacotherapy for pregnant womenSteve N Caritis, Prerna Dodeja, Shringi Sharma, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2008
Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birthShringi Sharma, Junhai Ou, Stephen Strom, et al.
British Journal of Clinical Pharmacology|February 24, 2025
Assessment of ethnic differences in pharmacokinetics and clinical responses of acalabrutinib between Chinese and White patients with B-cell malignanciesTingting Yao, Junjie Ding, Shringi Sharma, et al.
Pageof 4